OMX Copenhagen 20 Share Price

Index

OMXC20

DK0016268840

Market Closed - Nasdaq Copenhagen 08:35:00 31/05/2024 pm IST			5-day change	1st Jan Change
2,769 ^PTS	+0.92%		-0.76%	+21.27%

31/05	Nordic Shares Moved Upward Friday; NEL Topped Leaders	DJ
29/05	Nordic Stocks Dropped Wednesday; NEL Fell Furthest	DJ

Chart OMX Copenhagen 20

Duration

Period

Style

Dynamic Chart

Latest news about OMX Copenhagen 20

Nordic Shares Moved Upward Friday; NEL Topped Leaders	31/05	DJ
Nordic Stocks Dropped Wednesday; NEL Fell Furthest	29/05	DJ
Nordic Stocks Decreased Tuesday; Cadeler Posted Biggest Loss	28/05	DJ
Nordic Shares Moved Upward Monday; Sinch Led Increases	27/05	DJ
Nordic Stocks Rose Tuesday; Billerud Led Increases	21/05	DJ
Nordic Shares Decreased Friday; Nibe Industrier Series B Fell Furthest	17/05	DJ
Nordic Shares Moved Upward Wednesday; BioArctic Series B Topped Leaders	15/05	DJ
Nordic Shares Closed Up Tuesday; Volvo Car Series B Led Increases	14/05	DJ
Nordic Stocks Moved Upward Monday; OX2 Climbed Highest	13/05	DJ
Nordic Stocks Closed Down Wednesday; BYGGFAKTA Group Took Biggest Hit	08/05	DJ
Nordic Shares Closed Up Tuesday; Storskogen Group Series B Topped Leaders	07/05	DJ
Nordic Stocks Moved Upward Monday; Nolato Series B Led Increases	06/05	DJ
Nordic Shares Dropped Friday; Instalco Posted Biggest Loss	03/05	DJ
Nordic Stocks Closed Down Thursday; Lundin Mining Fell Furthest	02/05	DJ
Nordic Shares Moved Upward Tuesday; Hoegh Autoliners Topped Leaders	30/04	DJ

More news

News of the index components

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma GMAB	03/06	AQ
Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma GMAB	03/06	GL
Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma GMAB	03/06	BU
Genmab A/S : Investigational Acasunlimab (DuoBody® PD L1x4 1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non small Cell Lung Cancer (mNSCLC) GMAB	01/06	PU
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC) GMAB	01/06	BU
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC) GMAB	01/06	GL
Trading by management and close relations of management NSIS B	31/05	GL
Danske Bank A/S : Active Ownership Instruction DANSKE	31/05	PU
Danske Bank A/S : Human Rights Report 2023 DANSKE	31/05	PU
Wegovy maker Novo Nordisk sues nine spas, clinics and pharmacies over copycat drugs NOVO B	30/05	RE

No results for this search

More news

News in other languages on OMX Copenhagen 20

Índices: Europa del Norte frente a Europa del Sur y varios mapas térmicos	09/05
Indici: Nord Europa vs. Sud Europa e varie heatmap	08/05
Indices : Europe du Nord vs. Europe du Sud et heatmaps variées	08/05
Etwas leichter - Anspannung vor Auftritt der US-Notenbank	01/05
FTSE-100 tritt auf der Stelle - GSK fester	01/05